Study purpose


The objective of POLBOS LM is to establish the safety and efficacy of the BiOSS LIM C with respect to a Patient oriented Composite Endpoint (PoCE) at 12 months in a “real world” left-main bifurcation population and as compared with a prespecified performance goal (OPC).

PoCE is defined as a composite of all-cause mortality, stroke (mRS≥1), any myocardial infarction (includes non-target vessel territory), any unplanned revascularization for ischemia (includes all target and nontarget vessels).